These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2799280)

  • 1. Guidelines for evaluation of analytical interference.
    Scand J Clin Lab Invest Suppl; 1989; 195():7-9. PubMed ID: 2799280
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug effects in clinical chemistry. Part 2. Guidelines for evaluation of analytical interference.
    Galteau MM; Siest G
    J Clin Chem Clin Biochem; 1984 Mar; 22(3):275-9. PubMed ID: 6726127
    [No Abstract]   [Full Text] [Related]  

  • 3. IFCC Guidelines to the Evaluation of Drug Effects in Clinical Chemistry. Data banks.
    Scand J Clin Lab Invest Suppl; 1989; 195():22-4. PubMed ID: 2799279
    [No Abstract]   [Full Text] [Related]  

  • 4. International Federation of Clinical Chemistry (IFCC). Scientific Committee, Clinical Section. Expert Panel on Drug Effects in Clinical Chemistry (EPDECC). IFCC Document stage 2, draft 3, 1983-11 with a proposal for an IFCC recommendation. Drug effects in clinical chemistry. Part 2. Guidelines for evaluation of analytical interference.
    Clin Chim Acta; 1984 May; 139(2):223F-230F. PubMed ID: 6733933
    [No Abstract]   [Full Text] [Related]  

  • 5. IFCC Guidelines to the Evaluation of Drug Effects in Clinical Chemistry. The basic concepts.
    Scand J Clin Lab Invest Suppl; 1989; 195():5-6. PubMed ID: 2678422
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing (analytical) quality in clinical chemistry. Review of pertinent literature.
    Hørder M
    Scand J Clin Lab Invest Suppl; 1980; 155():7-10. PubMed ID: 7034149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Precautions to be taken for purposes of analyses].
    Laederer R; Lugon G; Montigel C; Platsoukas C; Rochat J; Scazziga B; Scoundrianos T; Siegenthaler P; Wuilleret B
    Rev Med Suisse Romande; 1972 Nov; 92(11):885-906. PubMed ID: 4662603
    [No Abstract]   [Full Text] [Related]  

  • 8. Present analytical quality in the Nordic clinical chemistry laboratories.
    Aronsson T; Bjørnstad P; Leskinen E; Uldall A; De Verdier CH
    Scand J Clin Lab Invest Suppl; 1980; 155():11-8. PubMed ID: 6948361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synopsis of methods for obtaining quality requirements in clinical chemistry.
    Solberg HE
    Scand J Clin Lab Invest Suppl; 1980; 155():29-30. PubMed ID: 6948365
    [No Abstract]   [Full Text] [Related]  

  • 10. Reference materials and methods in clinical chemistry. Report of a Discussion Group Meeting held on the occasion of the 1st European Congress of Clinical Chemistry. Munich, 23rd April 1974.
    Rinsler MG; Mitchell FL
    Z Klin Chem Klin Biochem; 1974 Dec; 12(12):558-74. PubMed ID: 4156105
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quality control of clinical-chemical examinations in clinical trial of drugs].
    Stamm D
    Arzneimittelforschung; 1971 Oct; 21(10):1517-9. PubMed ID: 5171876
    [No Abstract]   [Full Text] [Related]  

  • 12. Who defines the medical requirements of analytical tests?
    Guder WG; Schleicher E
    J Clin Chem Clin Biochem; 1990 Mar; 28(3):125-8. PubMed ID: 2329320
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of biological effects of drugs.
    Scand J Clin Lab Invest Suppl; 1989; 195():10-2. PubMed ID: 2678421
    [No Abstract]   [Full Text] [Related]  

  • 14. Analytical goals for interference.
    Fuentes-Arderiu X; Fraser CG
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():393-5. PubMed ID: 1892351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Codex foodstuffs committee FAO/WHO on methods of analysis and sampling].
    Cwiek-Ludwicka K; Jedrzejczak R
    Rocz Panstw Zakl Hig; 1994; 45(3):207-14. PubMed ID: 7777777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Justifying the lack of incurred sample reproducibility in a study: considerations and strategies.
    Gagnon-Carignan S; Lachance S; Saint-Laurent A; Gendron M; Lévesque A
    Bioanalysis; 2015; 7(2):221-7. PubMed ID: 25587838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory tests during clinical trials.
    Scand J Clin Lab Invest Suppl; 1989; 195():16-8. PubMed ID: 2799277
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioanalysis through the ages.
    Stevenson D
    Bioanalysis; 2011 Dec; 3(24):2681-3. PubMed ID: 22185263
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical laboratory tests on laboratory animals during toxicity studies.
    Scand J Clin Lab Invest Suppl; 1989; 195():13-5. PubMed ID: 2799276
    [No Abstract]   [Full Text] [Related]  

  • 20. Recommendations on ISR in multi analyte assays, QA/bioanalytical consultants and GCP by Global CRO Council for Bioanalysis (GCC).
    Sangster T; Maltas J; Struwe P; Hillier J; Boterman M; Doig M; Breda M; Garofolo F; Caturla MC; Couerbe P; Schiebl C; Pattison C; Goodwin L; Segers R; Garofolo W; Folguera L; Zimmer D; Zimmerman T; Pawula M; Tang D; Cox C; Bigogno C; Schoutsen D; de Boer T; Green R; Houghton R; Sable R; Siethoff C; Harter T; Best S;
    Bioanalysis; 2012 Jul; 4(14):1723-30. PubMed ID: 22877218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.